Overall, a collection of in vivo and in vitro results (summarized in Figure 4), including recent data from our laboratory, emphasize a regulatory role of leptin in VSMC activation and phenotypic transformation, central to the pathogenesis of atherosclerosis. The gene discussed is LEP; the disease is atherosclerosis.